Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so predictable routine of online calls and deadlines has, of course, returned. To cope, yes, we are firing up the coffee kettle and brewing cups of stimulation. Our choice today is the ever-seasonal pumpkin spice. Feel free to join us. Meanwhile, here is the latest batch of tidbits to get you going. We hope you have a productive day, and do keep in touch if you hear anything interesting. …
Democratic Party lawmakers holding up proposed drug-pricing reform are among the largest beneficiaries of a pharmaceutical industry push to stave off price cuts, a Reuters analysis of public lobbying and campaign data shows. The pharmaceutical industry, which traditionally gives more to Republicans, channeled around 60% of donated campaign funds to Democrats this year. The drug companies have spent over $177 million on lobbying and campaign donations in 2021. Nonprofit political action committees run by Pfizer (PFE) and Amgen (AMGN) and the Pharmaceutical Research and Manufacturers of America trade group were among the biggest donors.
In a letter to employees, former Athira Pharma (ATHA) chief executive officer Leen Kawas wrote she regrets that mistakes she made at Washington State University caused a distraction to the company, The Puget Sound Business Journal says. In her letter, Kawas admitted to enhancing images in her doctoral research but denied that she manipulated or changed the data. She added her research did not involve Athira’s current lead drug candidate, ATH-1017. Kawas was placed on temporary leave in June pending a review of her doctoral research. The company found she altered images in her dissertation and at least four papers she co-authored that were published between 2011 and 2014.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
